| Literature DB >> 28694755 |
Eun-Yi Ko1, Su-Hyeon Cho1,2, Kyungpil Kang3, Gibeom Kim3, Ji-Hyeok Lee2, You-Jin Jeon2, Daekyung Kim1, Ginnae Ahn4, Kil-Nam Kim5.
Abstract
The present study was performed to investigate the anti-inflammatory activity of Tetragonia tetragonoides hydrosols (TTH) and its underlying mechanism in lipopolysaccharide (LPS)-induced RAW 264.7 cells. Gas chromatography (GC) coupled with mass spectrometry and retention index calculations showed that TTH were mainly composed of tetratetracontane (29.5 %), nonacosane (27.6 %), and oleamide (17.1 %). TTH significantly decreased the production of nitric oxide (NO), prostaglandin E2 (PGE2), interleukin (IL)-6, and IL-1β in LPS-stimulated RAW 264.7 cells. Consistent with these observations, TTH treatment decreased the protein expression levels of inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2). The molecular mechanism of its anti-inflammatory activity was found to be associated with inhibition of nuclear factor-kappa B (NF-κB) phosphorylation and nuclear translocation of NF-κB 65. Furthermore, TTH markedly suppressed the LPS-induced phosphorylation of mitogen-activated protein kinases (MAPKs). Taken together, these data indicate that TTH exerts an anti-inflammatory activity by inhibiting the NF-κB and MAPK signaling pathways in LPS-stimulated RAW 264.7 cells.Entities:
Keywords: MAPKs; NF-kappaB; Tetragonia tetragonoides; anti-inflammatory; hydrosols
Year: 2017 PMID: 28694755 PMCID: PMC5491923 DOI: 10.17179/excli2017-121
Source DB: PubMed Journal: EXCLI J ISSN: 1611-2156 Impact factor: 4.068
Table 1Chemical composition of the TTH
Figure 1Effects of TTH on (A) cell viability and (B) NO and (C) PGE2 production in LPS-induced RAW 264.7 cells. Cells were pretreated for 1 h with different concentrations (0.5 %, 1 %, 2.5 % and 5 %) of TTH and then LPS (1 μg/ml) was added and incubated for 24 h. Cell viability was determined using the MTT assay. Values are expressed as means ± S.D. of triplicate experiments. *P < 0.05 indicate significant differences from the LPS-stimulated group.
Figure 2Effects of TTH on LPS-induced iNOS and COX-2 protein expressions in RAW 264.7 cells. Cells were treated for 1 h with different concentrations (0.5 %, 1 %, 2.5 % and 5 %) of TTH, LPS (1 μg/ml) was then added and cells were incubated for 24 h. iNOS and COX-2 protein level were determined via Western blotting. Density ratio of a TTH treated-group over LPS only treated-group was measured by densitometer.
Figure 3Effect of TTH on the pro-inflammatory cytokine production in LPS-induced RAW 264.7 cells. The production of (A) IL-6 and (B) IL-1β were assayed in the culture medium of cells stimulated with LPS (1 μg/ml) for 24 h in the presence of TTH (0.5 %, 1 %, 2.5 % and 5 %)). Supernatants were collected, and the IL-1β, IL-6, and TNF-α concentration in the supernatants were determined by ELISA. Values are expressed as means ± S.D. of triplicate experiments. *P < 0.05.
Figure 4Inhibitory effect of TTH on phosphorylation of MAPKs and NF-κB activation in LPS-induced RAW 264.7 cells. Cells were treated for 15 min with LPS (1 μg/ml) alone or with LPS (1 μg/ml) coupled with 5 % TTH. The expression levels of (A) NF-κB and (C) MAPKs protein were determined via Western blotting. Density ratio of a TTH treated-group over LPS only treated-group was measured by densitometer. (B) The p65 protein localization in cells was determined with an anti-p65 antibody and Alexa Fluor 488 goat anti-rabbit antibody by laser confocal scanning microscopy.